Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STIMPulseControl Ancillary Speech Study

NCT06561919 is registered in ClinicalTrials.gov with Steffen Paschen as lead sponsor.

NCT NCT06561919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06561919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STIMPulseControl Ancillary Speech Study
Lead sponsor
Steffen Paschen
Phase
Not applicable
Overall status
Recruiting
Start date
September 5, 2024
Completion date
July 15, 2028
Enrollment
60 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

impulse control disorder, parkinson disease